Synthesis of C-glycosylated compounds with the use of a mild,
iodine-catalyzed reaction
    3.
    发明授权
    Synthesis of C-glycosylated compounds with the use of a mild, iodine-catalyzed reaction 失效
    使用温和的碘催化反应合成C-糖基化化合物

    公开(公告)号:US5414074A

    公开(公告)日:1995-05-09

    申请号:US951529

    申请日:1992-09-25

    CPC分类号: C07D307/32 C07D309/30

    摘要: The invention concerns C-glycosylated derivatives of soft carbon nucleophile compounds, particularly compounds which contain acid-labile structural units. The invention further concerns a mild, cost-effective, non-hazardous and stereoselective method of general application employing a glycal as a glycosyulating agent and iodine as a catalyst for the preparation of C-glycosylated soft carbon nucleophile compounds.

    摘要翻译: 本发明涉及软碳亲核试剂化合物的C-糖基化衍生物,特别是含酸不稳定结构单元的化合物。 本发明还涉及使用甘氨酸作为糖基化剂和碘作为制备C-糖基化的软碳亲核化合物的催化剂的温和的,具有成本效益的,无危害的和立体选择性的一般应用方法。

    Glycosylated analogs of fusidic acid
    5.
    发明授权
    Glycosylated analogs of fusidic acid 失效
    夫西地酸的糖基化类似物

    公开(公告)号:US06462182B1

    公开(公告)日:2002-10-08

    申请号:US09616658

    申请日:2000-07-14

    IPC分类号: C07H1500

    CPC分类号: C07H13/04 C07H3/08

    摘要: Novel analogs of fusidic acid are described with one or more carbohydrate units attached. Certain glycosylated analogs of fusidic acid have enhanced solubility properties in diluents or excipient of choice as compared to unmodified fusidic acid. Certain glycosylated analogs may be employed as chemotherapeutic agents and particular analogs may be useful for fighting anti-microbial infections.

    摘要翻译: 描述了连接一个或多个碳水化合物单元的夫西地酸的新型类似物。 与未修饰的夫西地酸相比,夫西地酸的某些糖基化类似物具有增强的稀释剂或赋形剂的溶解性。 某些糖基化类似物可用作化学治疗剂,特定的类似物可用于抗菌抗感染。

    Process for preparing glycosylated analogs of camptothecin
    6.
    发明授权
    Process for preparing glycosylated analogs of camptothecin 失效
    制备喜树碱糖基化类似物的方法

    公开(公告)号:US5932709A

    公开(公告)日:1999-08-03

    申请号:US876824

    申请日:1997-06-16

    IPC分类号: C07H15/26 C07H17/00 C07H1/00

    CPC分类号: C07H15/26 C07H17/00

    摘要: The present invention relates to chemotherapeutic agents, and more particularly, to novel analogs of camptothecin. The camptothecin analogs display increased solubility through the hydrophilicity of added non-ionic sugar substituents. In accordance with the present invention, a member from the class of novel camptothecin analogs is to be delivered in vivo as a chemotherapeutic agent to fight cancer growth in the body.

    摘要翻译: 本发明涉及化学治疗剂,更具体地涉及喜树碱的新型类似物。 喜树碱类似物通过添加的非离子糖取代基的亲水性显示增加的溶解度。 根据本发明,来自新兴喜树碱类似物类的成员将作为化学治疗剂在体内递送以抵抗体内的癌症生长。

    Glycosylated analogs of fusidic acid
    7.
    发明授权
    Glycosylated analogs of fusidic acid 失效
    夫西地酸的糖基化类似物

    公开(公告)号:US06720307B2

    公开(公告)日:2004-04-13

    申请号:US10189242

    申请日:2002-07-02

    IPC分类号: A61K3170

    CPC分类号: C07H13/04 C07H3/08

    摘要: Novel analogs of fusidic acid are described with one or more carbohydrate units attached. Certain glycosylated analogs of fusidic acid have enhanced solubility properties in diluents or excipient of choice as compared to unmodified fusidic acid. Certain glycosylated analogs may be employed as chemotherapeutic agents and particular analogs may be useful for fighting anti-microbial infections.

    摘要翻译: 描述了连接一个或多个碳水化合物单元的夫西地酸的新型类似物。 与未修饰的夫西地酸相比,夫西地酸的某些糖基化类似物具有增强的稀释剂或赋形剂的溶解性。 某些糖基化类似物可用作化学治疗剂,特定的类似物可用于抗菌感染。

    Glycosylated analogs of camptothecin
    8.
    发明授权
    Glycosylated analogs of camptothecin 失效
    喜树碱的糖基化类似物

    公开(公告)号:US5677286A

    公开(公告)日:1997-10-14

    申请号:US429941

    申请日:1995-04-27

    CPC分类号: C07H15/26 C07H17/00

    摘要: The present invention relates to chemotherapeutic agents, and more particularly, to novel analogs of camptothecin. The camptothecin analogs display increased solubility through the hydrophilicity of added non-ionic sugar substituents. In accordance with the present invention, a member from the class of novel camptothecin analogs is to be delivered in vivo as a chemotherapeutic agent to fight cancer growth in the body.

    摘要翻译: 本发明涉及化学治疗剂,更具体地涉及喜树碱的新型类似物。 喜树碱类似物通过添加的非离子糖取代基的亲水性显示增加的溶解度。 根据本发明,来自新兴喜树碱类似物类的成员将作为化学治疗剂在体内递送以抵抗体内的癌症生长。